Status:
UNKNOWN
LUS to Assess Lung Injury After Lung Lobectomy
Lead Sponsor:
Hospital General Universitario de Valencia
Conditions:
Lung Neoplasm
Adult ALL
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of the study is to assess whether lung ultrasound is able to detect lung injury after lung resection surgery.
Detailed Description
Postoperative pulmonary complications (PPC) are common after lung resection surgery, with an incidence that ranges between 11-32%. As PPC are associated with worse outcomes, many studies aim to find p...
Eligibility Criteria
Inclusion
- Age \> 18
- ASA I-III
- Non-small cell lung neoplasm
- Elective lung lobectomy
- Under one-lung ventilation
Exclusion
- Pregnancy
- Respiratory tract infection the previous month
- Diagnosed pulmonary fibrosis
- Predicted FEV \< 40%
- Surgery that includes resection of the thoracic wall or the diaphragm
- Neoplasm metastasis
- Obesity class II or more (BMI ≥ 35 kg/m\^2)
- Risk of malnutrition CONUT \> 1
- Hemoglobin \< 10 g/dl
- Chronic kidney failure: glomerular filtration \< 60 ml/min/m\^2, nephrectomy, kidney transplantation
- Treatment with corticosteroids or immunosuppressive agents 3 months before surgery
- Transfusion of blood products during the previous 10 days
- Heart failure (New York Heart Association Functional Class 3 or 4) during the week before surgery.
- Heart valve diseases over stage B of the American College of Cardiology/American
- Heart Association Task Force on Practice Guidelines 2014
- Diastolic dysfunction
Key Trial Info
Start Date :
January 28 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 31 2021
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04755478
Start Date
January 28 2021
End Date
October 31 2021
Last Update
February 16 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital General Universitario de Valencia
Valencia, Spain, 46014